Antiplatelet treatment in essential hypertension: where do we stand? - Wikidata - awgldk - TriplyDB

Antiplatelet treatment in essential hypertension: where do we stand?

Antiplatelet treatment in essential hypertension: where do we stand?

http://www.wikidata.org/entity/Q38384163

about

Hyperthymic affective temperament and hypertension are independent determinants of serum brain-derived neurotrophic factor level

P2860

Q37138875-DD31A284-7171-4786-B2A8-4C7293B2681B

P2860

Antiplatelet treatment in essential hypertension: where do we stand?

http://www.wikidata.org/entity/Q38384163

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antiplatelet treatment in essential hypertension: where do we stand?

@en

type

label

Antiplatelet treatment in essential hypertension: where do we stand?

@en

prefLabel

Antiplatelet treatment in essential hypertension: where do we stand?

@en

P1433

Q38384163-B4D3D999-5C6F-4628-BC8E-3C2BF93BA408

P1476

Q38384163-02434F4C-505D-42B0-A767-A5018BA356C1

P2093

Q38384163-069A94E0-8AAB-47CE-ACDC-B3AE959DE43E

Q38384163-50ECEE1E-BB58-4920-8A5E-2556DA82D939

P2860

Q38384163-0495B941-64DD-4203-A610-F8823A3EB7FB

Q38384163-08ED13A3-339C-4BAB-A083-D3511749656E

Q38384163-13F9578C-A255-4A0A-82A8-0E9CC1E00401

Q38384163-14D187D4-1323-4CD9-8A0A-9A567B894B87

Q38384163-1A40EF75-3D1F-49F3-9551-FD5053C9A0E6

Q38384163-1EAD8E1A-BBE3-413D-878C-C8E1A61E2621

Q38384163-258C53C0-5572-4CB9-B24A-D1C3CC425497

Q38384163-277E568A-8CD9-44A0-8D9F-FE05F348FD85

Q38384163-28CD1CCA-3D73-4126-91D0-67BFF420F845

Q38384163-2CAD025E-2113-4601-9CE5-F41EA616141A

P2888

Q38384163-55F27854-46B6-4B35-8CCD-821340B7AB26

P304

Q38384163-190C3EE8-D7CC-447F-B034-023107E19C1D

P31

Q38384163-A8CE3DDB-89C9-4A03-8D7F-1588F70E4D10

P356

Q38384163-331F11AA-BC6A-475B-9F14-1C80E9F39612

P433

Q38384163-6087D269-93C8-47E1-B70F-0A4695B6AF02

P478

Q38384163-4E0E28C4-E23C-4F24-BB31-2AAEA97AE688

P50

Q38384163-919B0ABD-66F2-4D3E-9005-6158779CBF55

P577

Q38384163-028C77AE-EE3B-4E66-9F28-2EE18E90B74B

P5875

Q38384163-EC2F6512-A1DA-40FB-AA49-73EA827F05C2

P6179

Q38384163-B23411FE-44CD-4354-93FC-68FD00EA37EA

P698

Q38384163-556BB756-023B-4B47-B581-DF92C7E222A8

P356

S11906-015-0536-2

P1433

Current Hypertension Reports

P1476

Antiplatelet treatment in essential hypertension: where do we stand?

@en

P2093

Eugenia Gkaliagkousi

http://www.w3.org/2001/XMLSchema#string

Stella Douma

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Antiplatelet agents and anticoagulants for hypertension

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

P2888

s11906-015-0536-2

P304

536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-015-0536-2

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Eleni Gavriilaki

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273780001

http://www.w3.org/2001/XMLSchema#string

P6179

1003851027

http://www.w3.org/2001/XMLSchema#string

P698

25790800

http://www.w3.org/2001/XMLSchema#string